Mark Schumacher, MD, PhD

Director, PARC
Professor and Chief, Division of Pain Medicine
+1 415 502-7022

Dr. Schumacher's research focuses on the identification of novel analgesic targets in the peripheral nervous system to treat chronic pain without risk of addiction. Currently, he is investigating a class of transcription inhibitors previously used to treat cancer that now show promise to block pain from inflammation and nerve injury.

UCSF Research Profile

Publications